Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
16-02-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
12-02-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December, 2023
07-02-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
06-02-2024

Torrent Pharma Q3 Results Review - Strong Performance Across Branded Markets: Nirmal Bang

Domestic revenue grew by 12% YoY to Rs 14.15 billion.
06-02-2024

Torrent Pharmaceuticals Q3 FY24 Results Live: Profit Rises by 56.54% YoY

Revenue increased by 9.67% YoY & profit increased by 56.54% YoY
04-02-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
03-02-2024
Next Page
Close

Let's Open Free Demat Account